TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas

  1. Melo, M.
  2. Da Rocha, A.G.
  3. Vinagre, J.
  4. Batista, R.
  5. Peixoto, J.
  6. Tavares, C.
  7. Celestino, R.
  8. Almeida, A.
  9. Salgado, C.
  10. Eloy, C.
  11. Castro, P.
  12. Prazeres, H.
  13. Lima, J.
  14. Amaro, T.
  15. Lobo, C.
  16. Martins, M.J.
  17. Moura, M.
  18. Cavaco, B.
  19. Leite, V.
  20. Cameselle-Teijeiro, J.M.
  21. Carrilho, F.
  22. Carvalheiro, M.
  23. Máximo, V.
  24. Sobrinho-Simões, M.
  25. Soares, P.
Journal:
Journal of Clinical Endocrinology and Metabolism

ISSN: 1945-7197 0021-972X

Year of publication: 2014

Volume: 99

Issue: 5

Type: Article

DOI: 10.1210/JC.2013-3734 GOOGLE SCHOLAR lock_openOpen access editor